These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9631152)

  • 21. Ketoacidosis associated with protease inhibitor therapy.
    Besson C; Jubault V; Viard JP; Pialoux G
    AIDS; 1998 Jul; 12(11):1399-400. PubMed ID: 9708427
    [No Abstract]   [Full Text] [Related]  

  • 22. [Large, atypical accumumlation of adipose tissue in a patient with human immunodeficiency virus infection].
    García de la Llana F; Morales F
    Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):431-2. PubMed ID: 9887631
    [No Abstract]   [Full Text] [Related]  

  • 23. Indinavir--effect on sugar and insulin.
    TreatmentUpdate; 2001 Jun; 13(2):7-8. PubMed ID: 11570290
    [No Abstract]   [Full Text] [Related]  

  • 24. Frozen shoulder in HIV patients treated with indinavir: report of three cases.
    Peyriere H; Mauboussin JM; Rouanet I; Rouveroux P; Hillaire-Buys D; Balmes P
    AIDS; 1999 Nov; 13(16):2305-6. PubMed ID: 10563718
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection.
    Hirsch MS; Steigbigel RT; Staszewski S; McMahon D; Fischl MA; Hirschel B; Squires K; DiNubile MJ; Harvey CM; Chen J; Leavitt RY;
    Clin Infect Dis; 2003 Oct; 37(8):1119-24. PubMed ID: 14523778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indinavir gender study shows consistency.
    AIDS Patient Care STDS; 1998 Dec; 12(12):940-1. PubMed ID: 11362069
    [No Abstract]   [Full Text] [Related]  

  • 27. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrotoxicity of antiretroviral therapy in an HIV-infected patient.
    Said SM; Nasr SH; Samsa R; Markowitz GS; D'Agati VD
    Kidney Int; 2007 May; 71(10):1071-5. PubMed ID: 17311070
    [No Abstract]   [Full Text] [Related]  

  • 29. Paronychia in association with indinavir treatment.
    Colson AE; Sax PE; Keller MJ; Turk BK; Pettus PT; Platt R; Choo PW
    Clin Infect Dis; 2001 Jan; 32(1):140-3. PubMed ID: 11118393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One lump or two.
    Low H
    Notes Undergr; 1997; (No 35):1, 7. PubMed ID: 11364563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A patient's guide to protease inhibitors.
    Elperin A; Sax P
    AIDS Clin Care; 1996 Oct; 8(10):83-4. PubMed ID: 11363988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
    Nerad JL; Kessler HA
    Clin Infect Dis; 2001 Jun; 32(11):1635-6. PubMed ID: 11340537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Painful hyperaesthesia caused by protease inhibitors?
    Colebunders R; De Droogh E; Pelgrom Y; Depraetere K; De Jonghe P
    Infection; 1998; 26(4):250-1. PubMed ID: 9717686
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.
    Malavaud B; Dinh B; Bonnet E; Izopet J; Payen JL; Marchou B
    Antivir Ther; 2000 Mar; 5(1):3-5. PubMed ID: 10846585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lopinavir/ritonavir- and indinavir-induced thrombocytopenia in a patient with HIV infection.
    Colebunders R; De Schacht C; Vanwolleghem T; Callens S
    Int J Infect Dis; 2004 Sep; 8(5):315-6. PubMed ID: 15325601
    [No Abstract]   [Full Text] [Related]  

  • 36. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
    Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
    Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria.
    Perazella MA; Kashgarian M; Cooney E
    Clin Nephrol; 1998 Sep; 50(3):194-6. PubMed ID: 9776425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute renal failure due to indinavir crystalluria and nephrolithiasis: report of two cases.
    Berns JS; Cohen RM; Silverman M; Turner J
    Am J Kidney Dis; 1997 Oct; 30(4):558-60. PubMed ID: 9328372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indinavir-related alopecia.
    d'Arminio Monforte A; Testa L; Gianotto M; Gori A; Franzetti F; Sollima S; Bini T; Moroni M
    AIDS; 1998 Feb; 12(3):328. PubMed ID: 9517999
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary stones in HIV-1-positive patients treated with indinavir.
    Daudon M; Estépa L; Viard JP; Joly D; Jungers P
    Lancet; 1997 May; 349(9061):1294-5. PubMed ID: 9142068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.